Picture of Optimind Pharma logo

OMND Optimind Pharma Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Optimind Pharma, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2023
February 28th
2024
February 29th
2025
February 28th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
FinalFinalFinal
Cash
Cash and Equivalents
Cash and Short Term Investments0.0070.0010.5520.0290.084
Net Total Accounts Receivable
Net Total Receivables0.1160.1590.066
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.0110.0220.6680.1880.15
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0950
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets0.0110.0221.350.2380.2
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.0880.1880.6250.3670.275
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities0.0880.1880.7150.3670.275
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity-0.077-0.1660.64-0.129-0.075
Total Liabilities & Shareholders' Equity0.0110.0221.350.2380.2
Total Common Shares Outstanding